An internationally recognized healthcare research institution and medical center engaged CRA to assist it in preparing for negotiations with other treatment facility operators for the license of a proton treatment patent portfolio. As part of its work, CRA identified potential worldwide licensees, developed detailed financial models from the client’s and licensee’s perspective, and provided a negotiation preparation package for negotiations with potential licensees that included proposed financial term sheets under different license structures and sensitivity analyses.
CRA consultants recognized among leading IP professionals in the 2025 IAM Strategy 300
Daniel McGavock, Robert Goldman, and Dr. Richard Razgaitis were recognized as leading IP strategists by Intellectual Asset Management (IAM) in the latest...